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PRESCRIBING A LEGISLATIVE RESPONSE:
EDUCATORS, PHYSICIANS, AND
PSYCHOTROPIC MEDICATION FOR CHILDREN
Connie Lenz*
The prescription of psychotropic medication to children, particularly
stimulant medication to treat attention deficit disorders, has been the subject
of great debate for several decades and has focused attention on the practices
of both school personnel and physicians.' Educators have been accused of
pressuring parents to medicate students in order to facilitate classroom
management. Physicians have been faulted for too readily prescribing
psychotropic medication without following proper diagnostic and monitor-
ing procedures. Recently, Congress and state legislatures have made efforts
to address these perceived problems.
While there has been a dramatic increase in prescriptions to children for
all psychotropic medications over the past decade, 2 the analysis in this
article will focus on the diagnosis and treatment of Attention Deficit Hyper-
* Associate Director for Collection Development, University of Minnesota Law Library.
The author thanks Joan Howland and Mary Rumsey for editorial comments and encour-
agement.
1. RUSSELL BARKLEY, HYPERACTIVE CHILDREN: A HANDBOOK FOR DIAGNOSIS AND
TREATMENT, 191 (1981) (noting that in 1970, a major controversy developed over a
report in the Washington Post that erroneously stated that 5% - 10% of children in the
Omaha, Nebraska school system were being given stimulant drugs to control their
classroom behavior); Robert Maynard, Omaha Pupils Given 'Behavior' Drugs, WASH.
POST, June 29, 1970, at Al. The report prompted Congressional hearings on federal
involvement in the use of psychotropic medications for children. Federal Involvement in
the Use of Behavior Modification Drugs on Grammar School Children of the Right to
Privacy Inquiry: Hearing Before the Spec. Studies Subcomm. of the H. Comm. on Gov 't
Operations, 91st Cong. (1970) [hereinafter 1970 Hearings]; See also William W. Wells,
Note, Drug Control of School Children: The Child's Right to Choose, 46 S. CAL. L. REV.
585 (1973).
2. Julie Magno Zito et al., Psychotropic Practice Patterns for Youth: A 10-Year
Perspective, 157 ARCHIVES OF PEDIATRIC & ADOLESCENT MED. 17 (2003). See infra notes
42-51 and accompanying text.
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activity Disorder (ADHD).3 The diagnosis of ADHD and the use of stimu-
lant medications 4 to treat the disorder have been the subjects of a
longstanding, intense debate and numerous medical studies. The debate has
played out in school boards, courts, state legislatures and Congress. Largely
negative media attention, focused on the over-prescription of such medica-
tion, has shaped much of the debate. 5 The conclusions reached and
recommendations made in this article are not, however, limited to cases of
ADHD but may be applicable to the identification, diagnosis, and treatment
of other neurobehavioral disorders in children.6
Although the very existence of ADHD as a valid disorder has fueled much
debate,7 this article adopts the view supported by the mainstream medical
professional literature and assumes the validity of attention deficit disorders
and the use of stimulant medication in treatment when appropriate. 8 The
medical literature acknowledges that there are problems with the diagnosis
3. AMERICAN PSYCHIATRIC ASSOCIATION, DIAGNOSTIC AND STATISTICAL MANUAL
OF MENTAL DISORDERS 85-93 (4th ed. 2000) [hereinafter, DSM-IV]. DSM-IV criteria
identify three subtypes of ADHD: predominantly inattentive, predominantly hyperactive-
impulsive, and combined types. This article does not differentiate between the three types
and uses the term ADHD interchangeably.
4. Stimulant medications, including Ritalin, Concerta, and Adderall, are used to
treat attention deficit disorders. Strattera, a non-stimulant medication, is also used to treat
attention deficit disorder.
5. See infra notes 37 and 64.
6. While most legislative efforts to prohibit school personnel from recommending
or requiring psychotropic medication were initiated by concerns over stimulant medica-
tion, most enacted legislation ultimately included broad definitions of psychotropic
medication. See infra notes 135-36.
7. See Council on Scientific Affairs, American Medical Association, Council
Report: Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children
and Adolescents, 279 JAMA 1100, 1101 (1998) [hereinafter Council Report] (noting that
"highly inflammatory public relations campaigns and pitched legal battles have been
waged (particularly by groups such as the Church of Scientology) that seek to label the
whole idea of ADHD as an illness a 'myth' and to brand the use of stimulants in children
as a form of 'mind control').
8. Russell A. Barkley et al., International Consensus Statement on ADHD, January
2002, 5 CLINICAL CHILD & FAM. PSYCH. REV. 89, 90 (2002) ("To publish stories that
ADHD is a fictitious disorder or merely a conflict between today's Huckleberry Finns
and their caregivers is tantamount to declaring the earth flat, the laws of gravity debat-
able, and the periodic table in chemistry a fraud."); see also NIH Consensus Dev. Panel,
National Institutes of Health Consensus Development Conference Statement: Diagnosis
and Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD), 39 J. AM. ACAD.
CHILD & ADOLESCENT PSYCHIATRY 182 (2000) [hereinafter NIH Conference Statement];
Council Report, supra note 7, at 1101.
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and treatment of attention deficit disorders, 9 and many medical studies
suggest that stimulant medication is both over- and under-prescribed.' 0
These concerns are important to the analysis in this article.
According to the American Academy of Pediatrics (AAP), ADHD is the
most common neurobehavioral disorder of childhood and is among the most
prevalent chronic health conditions affecting school-aged children.' It is
estimated that approximately five percent of children will suffer from the
disorder during middle childhood.' The American Psychiatric Association
(APA) has established criteria for diagnosing ADHD. 13 These criteria
require that the child show six or more symptoms of either inattention 14 or
hyperactivity 15 for at least six months. At least some of the symptoms must
9. NIH Conference Statement, supra note 8, at 187 (noting the issues raised by the
wide variations in the use of psychostimulants across communities and physicians).
10. Id. at 186; Peter Jensen, et al., Are Stimulants Overprescribed? Treatment of
ADHD in Four U.S. Communities, 38 J. AM. ACAD. CHILD & ADOLESCENT PSYCHIATRY
797 (1999).
11. American Academy of Pediatrics, Committee on Quality Improvement, Sub-
committee on Attention-DeficitHyperactivity Disorder, Clinical Practice Guideline:
Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder,
105 PEDIATRICS 1158 (2000) [hereinafter AAP Diagnostic Guideline].
12. Hector R. Bird, The Diagnostic Classification, Epidemiology, and Cross-
Cultural Validity of ADHD, in ATTENTION DEFICIT HYPERACTIVITY DISORDER: STATE OF
THE SCIENCE, BEST PRACTICES 2-1, 2-6 (Peter S. Jensen and James R. Cooper, eds.,
2002).
13. DSM-IV, supra note 3, at 85-93.
14. Id. at 92. Symptoms of inattention include:
(a) often fails to give close attention to details or makes careless mistakes in
school work, work, or other activities; (b) often has difficulty sustaining atten-
tion in tasks or play activities; (c) often does not seem to listen when spoken to
directly; (d) often does not follow through on instructions and fails to finish
schoolwork, chores, or duties in the workplace (not due to oppositional behavior
or failure to understand instructions); (e) often has difficulty organizing tasks
and activities; (f) often avoids, dislikes, or is reluctant to engage in tasks that
require sustained mental effort (such as schoolwork or homework); (g) often
loses things necessary for tasks or activities (e.g., toys, school assignments,
pencils, books, or tools); (h) is often easily distracted by extraneous stimuli; (i)
is often forgetful in daily activities.
Id.
15. Id. Symptoms of hyperactivity include:
(a) often fidgets with hands or feet or squirms in seat; (b) often leaves seat in
classroom or in other situations in which remaining seated is expected; (c) often
runs about or climbs excessively in situations in which it is inappropriate; (d)
often has difficulty playing or engaging in leisure activities quietly; (e) is often
"on the go" or often acts as if "driven by a motor"; (f) often talks excessively;
Prescribing a Legislative Response
be present before the child is seven years old. Some impairment from the
symptoms must be present in two or more settings, generally home and
school. There must be clear evidence of clinically significant impairment in
social or academic functioning. Finally, the symptoms must not be better
accounted for by another mental disorder.
The diagnosis and treatment of ADHD in children necessarily involve
parents, school personnel, and medical practitioners. Teachers, who spend a
great deal of time observing children, may be the first to notice symptoms of
attention deficit disorder. Furthermore, under federal laws, school personnel
are required to identify students with disabilities that qualify those students
for special education services. 16 ADHD diagnostic and treatment guidelines
stress the importance of communication between school personnel and
physicians. 17 Such communication is important throughout diagnosis and
treatment and often involves the teacher providing results of assessments
and observations. Physicians are the professionals who must make a diagno-
sis, suggest a course of treatment, and prescribe medication if included in
that course of treatment. Parents, relying upon physicians' information-
sharing and recommendations, must ultimately decide upon a course of
treatment.
18
Unfortunately, medical practitioners, school personnel, and parents do not
always establish the necessary collaborative relationship when a child
exhibits symptoms of ADHD. In some instances, school personnel have
overstepped boundaries and have recommended, or even attempted to
require, the use of psychotropic medication for students. There also have
been cases where school personnel reported or threatened to report parents to
child protection services when parents refused to medicate a child. Medical
practitioners have been accused of misdiagnosis and of failure to provide
adequate information regarding medication side effects 19 or alternative
(g) often blurts out answers before questions have been completed; (h) often has
difficulty awaiting turn; and (i) often interrupts or intrudes on others (e.g., butts
into conversations or games).
Id.
16. See Section 11, infra, and accompanying notes.
17. See infra notes 88-108 and accompanying text.
18. While some criticize parents for playing a role in the over-prescription of
stimulant medication, this article does not address that issue. See Therese Powers, Race
for Perfection: Children's Rights and Enhancement Drugs, 13 J.L. & HEALTH 141, 147-
48 (1998-1999).
19. The package insert for Ritalin, the most widely prescribed stimulant medication,
includes the following statement regarding the most common "adverse reactions":
Nervousness and insomnia are the most common adverse reactions but are
usually controlled by reducing dosage and omitting the drug in the afternoon
or evening. Other reactions include hypersensitivity (including skin rash, urti-
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treatments. In the late 1980s and again in the early 2000s, these issues were
widely publicized as the subject of litigation. Recently, these issues have
emerged as subjects of legislative action.
This paper argues that state legislatures should enact legislation governing
both school personnel and medical practitioners with respect to the identifi-
cation, diagnosis, and treatment of children suffering from ADHD and other
neurobehavioral disorders. Part I gives a brief chronology of the stimulant
debate, adverse media attention, and litigation from the late 1980s to date.
Part 1I examines the role school personnel are required to play in identifying
students with ADHD. This section provides an overview of federal educa-
tion laws that require school personnel to consider whether a student has an
eligible disability requiring special education services. Part III reviews
current medical practice guidelines for the diagnosis and treatment of
ADHD, and provides a brief overview of the doctrine of informed consent.
Part IV examines recent legislative attempts to address school personnel
recommending or requiring psychotropic medication, and to regulate the
practice of physicians prescribing psychotropic medication to children. Part
V argues that state legislatures should pass legislation to guide both school
personnel and medical practitioners. Legislation should require local school
boards to adopt policies establishing procedures for school personnel work-
ing with students who exhibit symptoms of or who have been diagnosed
with ADHD or other neurobehavioral disorders. Similarly, legislation should
require medical boards or panels to establish training procedures and guide-
lines for medical practitioners who diagnose and treat children with ADHD
and other neurobehavioral disorders.
caria, fever, arthralgia, exfoliative dermatitis, erythema multiforme with
histopathological findings of necrotizing vasculitis, and thrombocytopenic
purpura); anorexia; nausea; dizziness; palpitations; headache; dyskinesia;
drowsiness; blood pressure and pulse changes, both up and down; tachycar-
dia; angina; cardiac arrhythmia; abdominal pain; weight loss during
prolonged therapy. There have been rare reports of Tourette's syndrome.
Toxic psychosis has been reported.... In children, loss of appetite, abdominal
pain, weight loss during prolonged therapy, insomnia, and tachycardia may
occur more frequently; however, any of the other adverse reactions listed
above may also occur.
NOVARTIS PHARMACEUTICAL CORP., RITALIN HYDROCHLORIDE METHYLPHENIDATE HYDRO-
CHLORIDE TABLETS USP (2001), available at http://www.fda.gov/cder/foi/label/2002/
18029slr0321bl.pdf.
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1. A CHRONOLOGY OF THE RITALIN DEBATE
The late 1980s and early 1990s saw a series of highly publicized cases
filed nationwide against medical professionals and educational professionals
regarding the diagnosis and treatment of children with ADHD.2 0 Almost all
of the actions included medical malpractice and informed consent claims
against physicians charged with misdiagnosis, failure to monitor, or failure
21to provide information regarding side effects. Many of the suits also
included claims of coercion or misrepresentation against school districts or
employees. 22 A sampling of these early actions clarifies the issues that arise
in the identification, diagnosis, and treatment of children with ADHD, and
demonstrates how these issues involve both medical practitioners and
educators.
In Lorenzo v. Yusin, 23 the plaintiff claimed that her eleven-year-old son
suffered permanent side effects, in the form of depression and headaches,
after taking Ritalin for three months and sued both her son's physician and
his school. The plaintiff alleged that the prescribing physician was negligent
in three ways: in diagnosing her son with ADHD, in failing to disclose
potential side effects of treating medications to her, and in raising the child's
dosage level at the request of school officials. 24 With respect to the school,
the plaintiff alleged that her son was coerced into taking Ritalin for three
months and was threatened with expulsion if he failed to do so. 2 5 The school
district argued that school personnel were simply following the physician's
20. Richard Welke, Litigation Involving Ritalin and the Hyperactive Child, 1990
DETROIT. C. L. REV. 125, at 149-61; Eileen M. Ouellette, Legal Issues in the Treatment of
Children With Attention Deficit Hyperactivity Disorder, 6 J. CHILD NEUROLOGY S68
(Supp. 1991); Diane Divoky, Ritalin: Education's Fix-It Drug?, 70 PHI BETA KAPPAN
599 (1989); Debra Cassens Moss, Ritalin Under Fire: 16 Lawsuits Claim Drug Was
Wrongly Prescribed, 74 A.B.A. J. 19 (1988).
21. Welke, supra note 20, at 157-60; Andrew Blum, Lawsuits Over Ritalin Spread to
Massachusetts, NAT'L L. J., Mar. 28, 1988, at 41.
22. Welke, supra note 20, at 157 n.143; James C. O'Leary, An Analysis of the Legal
Issues Surrounding the Forced Use of Ritalin: Protecting a Child's Right to "Just Say
No, " 27 NEw ENG. L. REV. 1173 (1993) (focusing on school personnel attempting to
require medication and arguing that any state attempt to regulate a child's behavior
through chemical means, absent exigent circumstances, is unconstitutional).
23. Lorenzo v. Yusin, No. NCC19439G (L.A. Super. Ct. Cal. filed Nov. 5, 1987).
24. Welke, supra note 20, at 158 n.151; see also Lori Grange, Ritalin Debate
Continues After Mistrial Ruling, L.A. TIMES, Dec. 13, 1990, at J9.
25. Welke, supra note 20, at 162 n.165; Grange, supra note 24.
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prescription and parent's instruction when they administered Ritalin. The
26case was never decided on its merits.
Parker v. American Psychiatric Association was a class action suit seek-
ing $125 million in damages from the Gwinnett County Board of Education,
the APA, and individual doctors. The lead plaintiff, LaVame Parker,
claimed that school officials threatened to expel her son if he did not take
Ritalin, and that four years of taking such psychotropic medication had made
him violent and suicidal. 28 The suit accused the APA of fraud,29 and the
doctors who prescribed the Ritalin of malpractice in the diagnosis, monitor-
ing, and treatment of the children. The physicians also were accused of
failing to inform plaintiffs of potentially serious side effects. The plaintiffs
also listed Gwinnett County Board of Education and various educators who
advocated the use of medication as defendants, arguing that their children's
due process rights had been violated by the schools' actions. The plaintiffs
accused all of the defendants of negligent misrepresentation regarding the
drug.
30
Valerie J. v. Derry Cooperative School District 1 involved an Individuals
with Disabilities Education Act (IDEA) claim. 32 This case involved a
twelve-year-old student, Casey J., who had behavioral problems from the
time he entered school. Casey J. began taking Ritalin just prior to entering
first grade. While the Ritalin seemed to help his concentration, his behav-
ioral problems continued. After almost two years, his parents discontinued
the medication, and were thereafter strongly opposed to medicating their
son. The following school year, at the suggestion of the school psychologist,
Casey J. was evaluated by a team of physicians at Children's Hospital in
Boston. The team believed that Casey J.'s problems were behavioral, and
included hyperactivity and attention deficit disorder. The team made sixteen
recommendations, including both classroom accommodations and the trial
use of the drug Cylert. The school then attempted to incorporate the use of
26. See Grange, supra note 24. A mistrial was declared on the fourth day of trial,
when the plaintiff introduced allegations of racism which the judge had ordered excluded
from testimony.
27. Parker v. Am. Psychiatric Ass'n, No. C87-2444A (N.D. Ga. filed Nov. 9, 1987;
voluntarily dismissed, Mar. 3, 1988).
28. Virginia S. Cowart, The Ritalin Controversy: What's Made This Drug's Oppo-
nents Hyperactive?, 259 JAMA 2521, at 2522 (1988).
29. See id The fraud claim was based on the APA's definition of attention deficit
hyperactivity disorder, which the plaintiffs argued is overly broad.
30. Moss, supra note 20; see also Andrew Blum, Legal Attack on Ritalin Expands,
NAT'L L. J., Nov. 23, 1987, at 16.
31. Valerie J. v. Derry Coop. Sch. Dist., 771 F. Supp. 483 (D.N.H. 1991).
32. 20 U.S.C. §§ 1400-1482 (2000). See also infra notes 74-78 and accompanying
text.
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medication into Casey J.'s Individualized Education Program (IEP). 33 The
court held that the student's "right to a free appropriate public education
could not be premised on the condition that he be medicated without his
parents' consent." 34 Consequently, the plaintiffs were awarded compensa-
tory damages.
35
With the exception of Valerie J., none of the late 1980s suits led to either
a successful verdict or a financial settlement. 36 The suits did, however,
attract widespread negative media attention regarding the use of psychotro-
pic medication for children.
37
For a brief period, the media attention had a chilling effect on the use of
Ritalin and other stimulant medication, particularly in cities where such
cases were litigated. 38 Researchers found a significant decrease in medica-
tion rates in the late 1980s and early 1990s in Baltimore County, 39 where a
33. 20 U.S.C. § 1414(d) (2000).
34. Valerie J., 771 F. Supp. at 490.
35. Id. at 491-492 (awarding plaintiff compensatory education for the seven and one-
half months that school district had failed to provide appropriate education, in addition to
monetary damages for that time period under 42 U.S.C. § 1983).
36. Daniel J. Safer, The Impact of Recent Lawsuits on Methylphenidate Sales, 33
CLINICAL PEDIATRICS 166 (1994); but see Ouellette, supra note 20, at S71 (citing an
earlier case, Benskin v. Taft City Sch. Dist., No. 16,431 (Kern City, Cal., filed June 30,
1980), that settled out of court for $250,000).
37. Valerie J., 771 F. Supp. at 484 (noting that "[t]his case is different from most
cases under the Act [IDEA] in that the parents of Casey J. went public and his case
garnered national attention as articles were published in People Magazine and the J.'s
appeared on Nightline and the Geraldo Rivera television show."); Grange, supra note 24;
Cowart, supra note 28, at 2521; Divoky, supra note 20, at 603-05; Carol Angel, Lawsuits
Mount Over Drugs Given Children, L.A. DAILY J., June 10, 1988, at 5. See also Welke,
supra note 20, at 125 n. I (noting numerous articles addressing negative media attention).
38. Safer, supra note 36, at 166.
The eight metropolitan areas that experienced anti-Ritalin lawsuits in 1987-
1988 had an average decline of 37% in estimated methylphenidate [Ritalin]
sales from 1986-1987 to 1990, whereas during that same period, the nonlitiga-
tion cities in nearby states had virtually no change in medication usage.... In the
nation as a whole, estimated sales of methylphenidate declined an average of
13% over the period from 1986 through 1990.
Id.
39. Daniel J. Safer & John M. Krager, Effect of a Media Blitz and a Threatened
Lawsuit on Stimulant Treatment, 268 JAMA 1004 (1992) (reporting that the medication
rate for the treatment of hyperactive/inattentive students in Baltimore County declined
39% in the 1989 and 1991 surveys from its peak in 1987, in contrast to the doubled rate
every 4 to 7 years from 1971 through 1987).
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threatened lawsuit had been highly publicized.40 Their report concluded that
"strong circumstantial evidence" suggested that the county's 1989 and 1991
declines in medical stimulant initiation were a reflection of parent, educator,
and medical professional trepidation over the threatened lawsuit and the
intense media blitz surrounding it. 41
While Ritalin use may have declined in the late 1980s and early 1990s,
prescriptions for Ritalin and other psychotropic medications for children
again climbed during the mid-I 990s.4 2 A recent study, including over
900,000 youths and nine classes of medication, found that between 1987 and
1996 the proportion of children under the age of twenty treated with psycho-
tropic drugs in three large healthcare systems doubled and, in some cases,
even tripled.43 While prescriptions for all psychotropic medications included
in the study increased over the decade, stimulant medications and antide-
pressants were the most highly prescribed medications. 4 Comparing rates of
treatment between 1987 and 1997, researchers found that there was a sig-
nificant increase in the overall rate of treatment of childhood ADHD, rising
from approximately 493,000 treated children in 1987 to 2,158,000 treated
children in 1997.
4 5
40. Ritalin Action Not Filed, NAT'L L. J., June 13, 1988, at 6. The Baltimore County
school district was publicly threatened with a lawsuit over educators' alleged role in
proposing treatment for possibly hyperactive children. The threatened suit was dropped
after the school district issued a memo warning staff not to suggest that Ritalin be used to
treat hyperactive children. Id.
41. Safer & Krager, supra note 39.
42. Zito, supra note 2, at 18 (noting that most of the growth in psychotropic medica-
tion prevalence in their study took place after 1991); Jerry L. Rushton & J. Timothy
Whitmire, Pediatric Stimulant and Selective Serotonin Reuptake Inhibitor Prescription
Trends: 1992 to 1998, 155 ARCHIVES OF PEDIATRIC & ADOLESCENT MED. 560 (2001);
Daniel J. Safer, Julie M. Zito, & Eric M. Fine, Increased Methylphenidate Usage for
Attention Deficit Disorder in the 1990s, 98 PEDIATRICS 1084 (1996).
43. Zito, supra note 2, at 17.
44. Id. at 22. Antidepressants, which include Prozac, Paxil, Zoloft, and Luvox, are
used to treat depressive disorders. Recently, the FDA has warned of increased suicidal
behavior in patients, particularly children and adolescents, being treated with antidepres-
sants. Ctr. for Drug Evaluation and Research, U.S. Food and Drug Admin., Suicidality in
Children and Adolescents Being Treated With Antidepressant Medications, FDA PuB.
HEALTH ADVISORY, Oct. 15, 2004, available at http://www.fda.gov/cder/drug/
antidepressants/SSRIPHA20041 0.htm.
45. Mark Olfson, et al., National Trends in the Treatment of Attention Deficit
Hyperactivity Disorder, 160 AM. J. PSYCHIATRY 1071, at 1073-74 (2003). Researchers
found increases in treatment rates in nearly every demographic group studied. Large
numbers of older children, children from lower-income families, children without health
insurance, and, to a lesser extent, children from racial and ethnic minority groups were
brought into treatment. Children treated for ADHD tended to receive fewer visits but
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The medical literature identifies several factors that may have contributed
to the increased medication rates in the 1990s. In 1991, the U.S. Department
of Education recognized ADHD as a disability that made students eligible
for special education services. This, in addition to the development of easily
administered instruments to be used by parents and teachers for assessing
behavioral problems, may have increased recognition of ADHD.4 6 In the
early 1990s, the negative publicity formerly associated with the Ritalin
lawsuits ceased and stimulant medication developed a more positive image
through advocacy campaigns of groups such as Children and Adults with
Attention Deficit/Hyperactivity Disorder (CHADD). 47 Patients began to
receive longer courses of treatment,48 and broader diagnostic criteria intro-
duced in 1994 most likely led to more children being diagnosed with
ADHD. 49 By the end of the 1990s, pharmaceutical companies also had
started direct marketing of medication. Finally, changes in the healthcare
system created financial incentives that favored medication over counseling
and other types of therapy.
51
Notably, the medical literature does not identify school personnel promot-
ing medication as a factor contributing to increased medication rates. In
2000, however, high profile litigation once again focused negative media
attention on educators' role in promoting Ritalin use. Two New York
more complex medication regimens. The researchers also found that most children who
received treatment for ADHD used one or more classes of psychotropic medication. Id.
See also Mark Olfson, et al., National Trends in the Use of Psychotropic Medications by
Children, 41 J. AM. ACAD. CHILD & ADOLESCENT PSYCHIATRY 514 (2002) (reporting a
dramatic increase from 1987 to 1996 in the use of psychotropic medications by children
in the United States, cutting across age, racial/ethnic, geographic, gender, and insurance
groups, and including stimulants, antidepressants, and other psychotropic medications).
46. Olfson, National Trends 2003, supra note 45, at 1074-75.
47. Id. at 1075.
48. Council Report, supra note 7, at 1105.
49. Olfson, National Trends 2002, supra note 45, at 518:
As compared with DSM-I11-R (1987), DSM-IV (1994) reduced the number of
symptoms required to meet ADHD criteria from eight to six, a subtype limited
to symptoms of inattention was created, and a residual category 'ADHD, not
otherwise specified' was added for individuals with prominent symptoms that
do not meet full ADHD criteria.
Id. See also Council Report, supra note 7, at 1102.
50. Viveca Novac, New Ritalin Ad Blitz Makes Parents Jumpy, TIME, Sept. 10, 2001,
at 62; Kate Zemike and Melody Petersen, School's Backing of Behavior Drugs Comes
Under Fire, N.Y. TIMES, Aug. 19, 2001, at A I (describing direct marketing campaigns of
Ritalin's competitors).
51. Michael S. Jellinek, Mirror, Mirror on the Wall: Are We Prescribing the Right
Psychotropic Medications to the Right Children Using the Right Treatment Plan?, 157
ARCHIVES OF PEDIATRIC & ADOLESCENT MED. 14, at 15 (2003).
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52
cases, in which schools attempted to require parents to place their children
on medication, received widespread attention, focusing on schools' role in
promoting and even mandating medication. 53 In both of these cases, school
personnel reported parents to the state's child protective services agency
when the parents refused to continue medicating their children.
In the Carroll case, parents were charged with educational neglect when
they decided to remove their son from medication because he was suffering
negative side effects.54 In court, the law guardian supported the school
district's position that the family should be required to address the child's
condition. Ultimately, the Carrolls consented to an adjournment in contem-
plation of dismissal, which directed the parents to comply with the doctor's
treatment regimen, including a prescription for Ritalin, or find some medi-
cally approved alternative.
55
In the Weathers case, school officials filed a complaint with the state's
Department of Child Protective Services alleging medical and educational
52. John Caher, Issue Puts Parents, Courts on Collision Course, N.Y. L.J., Aug. 17,
2000, at I (discussing Kyle Carroll's case); Weathers v. Millbrook Central Sch. Dist., No.
02-CV-7622 (S.D.N.Y. filed Nov. 4, 2002; scheduling order issued Feb. 17, 2004
requiring that parties are ready for trial by July 1, 2005),
http://www.sskrplaw.com/adhd/weathers.html [hereinafter Weathers Complaint].
53. In addition to new publicity about Ritalin in schools, there was also publicity
about three class action lawsuits filed in Texas, California, and New Jersey in 2000.
These suits were filed against the manufacturer of Ritalin, Ciba/Novartis, the American
Psychiatric Association (APA) and Children and Adults with Attention Deficit Disorder
(CHADD). The suits charged the drug manufacturer with conspiring with the APA and
CHADD to invent and promote the ADD/ADHD diagnosis in order to promote Ritalin
sales. Vess v. Ciba-Geigy Corp., No. 00-CV-1839, 2001 WL 290333 (S.D. Cal. 2001),
aff'd in part, rev'd in part, and remanded 317 F.3d 1097 (9th Cir., 2003); Dawson v.
Ciba-Geigy Corp., 145 F.Supp.2d 565 (D.N.J. 2001); Hernandez v. Ciba-Geigy Corp.,
200 F.R.D. 285 (S.D. Tex. 2001). These cases did not name school personnel or individ-
ual physicians as defendants and are, therefore, ancillary to this article beyond the extent
to which they attracted media attention and helped to further shape public opinion about
stimulant medication. See also Davis v. Francis Howell School Dist., 138 F.3d 754 (8th
Cir. 1998) and DeBord v. Bd. of Educ. of the Ferguson-Florissant Sch. Dist., 126 F.3d
1102 (8th Cir. 1997) (both holding that school districts did not discriminate against
students by refusing to administer Ritalin in a dosage above that which was recom-
mended in the PDR). These cases did not receive widespread media attention. For an
academic review of these cases, see Ann Chiumino, Class Action Suits Prompt Govern-
mental Action to Examine Ritalin Use and Regulation, 13 Loy. CONSUMER L. REV. 380,
392 (2001); Rex R. Schultze, Reading, Writing and Ritalin: The Responsibility of Public
School Districts To Administer Medications to Students, 32 CREIGHTON L. REV. 793
(1999).
54. Caher, supra note 52, at 2.
55. Id.
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neglect when parents took their son off psychotropic medication. 56 Due to
adverse side effects, the parents discontinued their son's medications,
57
despite the school's and the psychiatrist's insistence that they try alternative
prescriptions. Shortly after medication was discontinued, the student was
constructively dismissed from the school.55 The school district initially
agreed to provide homebound instruction, but stopped such instruction soon
after its implementation because it did not deem "psychiatric reasons" for
absence from school to be "medical reasons." The school then filed a report
with Child Protective Services and the Weathers were charged with neglect
for failing to give their son "the necessary medication" and not hospitalizing
him as advised by the psychiatrist. The Weathers avoided having their son
removed from custody when they produced an independent psychiatrist's
evaluation stating that their son did not require hospitalization.
Patricia Weathers filed suit in federal court in September 2002. She claims
that the principal, school district, and school psychologist were negligent,
and that they violated her son's constitutional rights by coercing his parents
to medicate him and banning him from school unless he was medicated.6 °
The suit also charges two doctors and the school psychologist with medical
malpractice for misdiagnosis without proper examination. Finally, all
defendants are accused of medicating the plaintiffs son without his or his
mother's informed consent.
Ritalin litigation and the media attention that it has received have shaped
public opinion about the use of stimulant medication, and, at times, may also
have influenced the professional judgments of medical practitioners,
61
56. Weathers Complaint, supra note 52; Behavioral Drugs in Schools: Questions
and Concerns: Hearing Before the Subcomm. on Oversight and Investigations of the H.
Comm. on Education and the Workforce, 106th Cong. 4-6 (2000). [hereinafter Hearings
on Behavioral Drugs in Schools] (statement of Patricia Weathers); see also Amy L.
Komoroski, Stimulant Drug Therapy for Hyperactive Children: Adjudicating Disputes
Between Parents and Educators, 11 B.U. PUB. INT. L.J. 97, 102 (2001).
57. The child was originally taking Ritalin, and eventually had switched to a combi-
nation of Dexedrine and Paxil. Weathers Complaint, supra note 52.
58. Id. The school principal informed the Weathers that "[w]e [the school and the
staff, including teachers and social workers] have nothing more to offer Michael," and
that "a different placement was probably the best solution for Michael." Michael now
receives homebound instruction. Id.
59. Hearings on Behavioral Drugs in Schools, supra note 56, at 5.
60. Weathers Complaint, supra note 52.
61. Safer & Krager, supra note 39, at 1007 (suggesting that increased physician
concern was a contributing factor to the decline in stimulant treatment in the late 1980s);
Cowart, supra note 28, at 2521 (noting that the wave of adverse publicity has raised
concern that public opinion may affect medical practice).
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educators, 62 and even courts. 63 While many of the suits named both medical
practitioners and school personnel, the media's coverage over the past few
years has increasingly focused on schools. 64 This criticism has shaped both
the public's perception that school personnel promote psychotropic medica-
tion and the course pursued by legislators in attempting to address the
65perceived over-prescription problem. While some state legislatures have
considered laws governing physicians who diagnose and treat children with
ADHD and other neurobehavioral disorders, most of the legislation has
been aimed at school personnel.
II. FEDERAL SPECIAL EDUCATION LAWS
Critics of psychotropic medication for children portray school personnel
as promoters of medication as a means of behavioral control or as a class-
room management tool. 6 7 While the cases and anecdotal accounts suggest
62. Safer & Krager, supra note 39, at 1007 (noting school personnel's apprehension
about potential liability and adverse publicity as a contributing factor to the decline in
stimulant treatment in the late 1980s).
63. Kristen L. Aggeler, Is ADHD a "Handy Excuse"?: Remedying Judicial Bias
Against ADHD, 68 UMKC L. REv. 459, 459 (2000).
64. For example, in August 2002, the New York Post began a series of articles on
schools pressuring parents to medicate their children. The series began with a story about
the Weathers case. These articles included many anecdotal accounts of school personnel
pressuring parents. Douglas Montero, I Was Told to Dope My Kid: RX Cocktail Making
Her Son Psychotic, N.Y. POST, Aug. 7, 2002, at 6; Douglas Montero, Mom's Private RX:
Transfers Son Over PS 28 Ritalin Push, N.Y. POST, Aug. 8, 2002, at 9; Douglas Montero,
Schools Pill-oried: Parents Forced to Drug Kids: Activist, N.Y. POST, Aug. 9, 2002, at
11; Douglas Montero, Parents Tell of School Pill Pushers' Extortion, N.Y. POST, Aug.
11, 2002, at 8; Douglas Montero, Give Pill Parents a Hot Line, Not a Cold Shoulder,
N.Y. POST, Aug. 12, 2002, at 6. See also, Craig Colgan, Don't Get Rattled Over Ritalin,
ED. DIGEST, Feb. 2001, at 63 (asserting "[d]on't make schools into the whipping posts on
this").
65. Infra notes 132-50 and accompanying text.
66. Infra notes 161-70 and accompanying text.
67. Craig S. Lerner, "Accommodations "for the Learning Disabled: A Level Playing
Field or Affirmative Action for Elites?, 57 VAND. L. REV. 1043, at 1069 (2004) (noting
the "incentives of overworked teachers to diagnose troublesome students as
ADD/ADHD, and thereby medicate them into some preferred condition"); Komoroski,
supra note 56, at 99-100 (examining the "aggressive promotion of Ritalin by educational
institutions"); Powers, supra note 18, at 148 (noting that "schools may encourage the
prescription of Ritalin to create an easier environment for teachers who do not want to
take the extra time to address the borderline children who need extra help," and asserting
that the "ultimate pressure for the use of Ritalin comes from school administrators");
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that such advocacy has occurred in some instances, there is no data with
respect to how often it occurs. Furthermore, the criticism of school personnel
does not address the federal requirement that school personnel identify
students with special education needs in order to fulfill their obligation to
provide necessary special educational services.
The Individuals with Disabilities Education Act (IDEA) 68 and Section 504
of the Rehabilitation Act (Section 504)69 both apply to the education of
disabled students. In complying with their obligations under these laws,
educators must determine whether students have qualifying disabilities.
Although the Individuals with Disabilities Education Improvement Act of
2004 now mandates that state educational agencies develop policies prohib-
iting school personnel from requiring medication as a condition to attending
school or receiving an evaluation or services under the Act, school person-
nel must still become involved in some preliminary diagnostic activity in
determining whether a student has a qualifying disability. In fact, the U.S.
Department of Education has published a resource document for teachers,
addressing the identification and treatment of ADHD.72 This document
includes a section on "Legal Requirements for Identification of and Educa-
tional Services for Children with ADHD."
73
IDEA provides funding to state education agencies to support special edu-
cation and related services to children with disabilities. A student with
Jeanie Russell, The Pill That Teachers Push: Ritalin, GOOD HOUSEKEEPING, Dec. 1997, at
110.
68. 20 U.S.C. §§ 1400-1482 (2000), reauthorized and amended by The Individuals
with Disabilities Education Improvement Act of 2004, Pub. L. No. 108-446, 118 Stat.
2647 (effective July 1, 2005).
69. 29 U.S.C. § 794 (2000).
70. See infra notes 147-50 and accompanying text.
71. Mark L. Wolraich, Current Assessment and Treatment Practices in ADHD,
ATTENTION DEFICIT HYPERACTIVITY DISORDER: STATE OF THE SCIENCE, BEST PRACTICES
23-8 (Peter S. Jensen and James R. Cooper, eds., 2002).
72. OFFICE OF SPECIAL EDUC. PROGRAMS, OFFICE OF SPECIAL EDUC. & REHABILITA-
TIVE SERVICES, U.S. DEP'T OF EDUC., IDENTIFYING AND TREATING ATTENTION DEFICIT
HYPERACTIVITY DISORDER: A RESOURCE FOR SCHOOL AND HOME (2003), available at
http://www.ed.gov/teachers/needs/speced/adhd/adhd-resource-pt I .doc [hereinafter
RESOURCE FOR SCHOOL AND HOME].
73. Idat 5. This article cites to the information contained in RESOURCE FOR SCHOOL
AND HOME, as this is information published by a federal agency and intended to provide
guidance to school personnel.
74. 20 U.S.C. § 1404(3)(A) (2000). A "child with a disability" is defined as a child:
(i) with mental retardation, hearing impairments (including deafness), speech or
language impairments, visual impairments (including blindness), serious emo-
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ADHD may qualify under IDEA under the category of "Other Health
Impairment," if the disability results in:
limited strength, vitality, or alertness, including a heightened alert-
ness to environmental stimuli that results in limited alertness with
respect to the educational environment, that is due to chronic or
acute health problems such as ... attention deficit disorder or at-
tention deficit hyperactivity disorder ... and [a]dversely affects a
child's educational performance.75
Under IDEA, each school district must conduct a full and individual
evaluation for each child being considered for special education and related
services. 76 A team of school professionals and the child's parents will use
the evaluation results to determine whether the child qualifies as a "child
with a disability under IDEA." 77 While a medical practitioner's diagnosis of
ADHD may be an important evaluation result, the diagnosis does not neces-
sarily qualify that child as eligible for special education and related services
under IDEA.
78
Although a child may not qualify for services under IDEA, he or she may
meet the requirements of Section 504, which requires a free appropriate
education for all children who have an impairment that substantially limits
one or more major life activities.79 If a child's ADHD adversely affects his
or her learning, which is a major life activity, the student may qualify for
services under Section 504. 80 To be considered eligible under Section 504,
an evaluation must show that the student's disability interferes with the
learning process and that the disability requires special education or related
services.
To determine if the student has a qualifying disability requiring special
education or related services under either IDEA or Section 504, the school
district, in cooperation with parents, must conduct an evaluation. This
evaluation can include three components: behavioral, educational, and
medical. 81 The behavioral evaluation can make use of standard question-
naires, and should collect information about the child's ADHD symptoms
from several different sources, which may include the child's parents,
tional disturbance..., orthopedic impairments, autism, traumatic brain injury,
other health impairments, or specific learning disabilities; and
(ii) who, by reason thereof, needs special education and related services."
Id.
75. 34 C.F.R. § 300.7(c)(9) (2004).
76. 20 U.S.C. § 1414 (2000)
77. 20 U.S.C. § 1414(b)(4) (2000).
78. RESOURCE FOR-SCHOOL AND HOME, supra note 72, at 5.
79. Id.
80. 34 C.F.R. § 104.3(j) (2004)
81. RESOURCE FOR SCHOOL AND HOME, supra note 72, at 6.
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teachers, and medical practitioners. The educational evaluation involves
classroom observations, a review of the child's productivity, and a review of
the child's academic record, to assess the extent to which the child's ADHD
impairs his or her performance at school.83 IDEA does not require that the
school conduct a medical evaluation to determine whether a child has
ADHD. If, however, the school believes that such an evaluation is necessary
to determine whether the student meets the eligibility criteria under IDEA,
the school must ensure that a medical evaluation is conducted at no cost to
the parents.
84
Given that school personnel are required to engage in some form of pre-
liminary diagnostic activity in order to "identify" students with disabilities,
the line between "identification" and "diagnosis" can blur. Likewise, while
school personnel can recommend a medical evaluation to determine whether
a student suffers from ADHD or some other neurobehavioral disorder,
educators must make sure that they do not appear to be recommending
consultation with a medical practitioner for the purpose of obtaining a
specific diagnosis or receiving any particular prescribed treatment. While
many instances of overstepping reported in anecdotal accounts may have
been well-intentioned efforts to assist parents and students,85 it is clear that
school personnel need stronger guidelines to ensure that they do not cross
appropriate boundaries or create the perception that they are recommending
or attempting to require medical treatment.
111. MEDICAL PRACTICE
While it is certainly inappropriate for school personnel to make medical
recommendations or requirements, medical practitioners are ultimately
responsible for any over-prescription of psychotropic medication for chil-86 ..
dren. Even if a teacher attempts to diagnose a neurobehavioral disorder and
recommend a course of treatment, the medical practitioner is responsible for
82. Id. at 6-7.
83. Id. at 7-8.
84. Id. at 8-9.
85. See, e.g., Valerie J. v. Derry Coop. Sch. Dist., 771 F. Supp. 483, 489 (D.N.H.
1991) (noting that school district authorities "acted with the patience of Job"); id. at 485
(noting that the physician at Children's Hospital in Boston was "quite impressed when
school members appeared [at a meeting at the hospital] showing concern for Casey J. as
this was unusual for school members to come to Boston").
86. Angel, supra note 37 (quoting plaintiff's attorney in Parker who admitted that he
did not view schools as the true "culprits," but rather doctors and psychologists).
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conducting a thorough evaluation and making any diagnosis. In addition,
only a medical practitioner can prescribe medication to the child.8
7
A. Diagnosis and Treatment of ADHD
The American Academy of Pediatrics (AAP) has issued two clinical prac-
tice guidelines8 8 addressing the diagnosis and treatment of ADHD. 89 These
guidelines make clear that diagnosis and treatment of ADHD necessarily
involve medical professionals, parents, and school personnel. Researchers
have found, however, that these guidelines are not widely followed.
87. Welke, supra note 20, at 158-59 (observing that "[i]t is clear that, if a physician
renders a diagnosis of ADH primarily on the basis or claims of an exasperated teacher
who remarks that something needs to be done with a particular child, then he has clearly
breached accepted medical diagnostic criteria and is liable for malpractice").
88. Practice guidelines are a means of professional self-regulation and set out
standards of conduct for members of the professional group. While these guidelines are
not legally binding, courts may consider such guidelines in defining appropriate standards
of care. For a discussion of the evolution and legal status of professional guidelines, see
Angela Campbell and Kathleen Cranley Glass, The Legal Status of Clinical and Ethics
Policies, Codes, and Guidelines in Medical Practice and Research, 46 McGILL L.J. 473
(2001).
89. AAP Diagnostic Guideline, supra note 11; American Academy of Pediatrics,
Comm. on Quality Improvement, Subcomm. on Attention-Deficit/Hyperactivity Disor-
der, Clinical Practice Guideline: Treatment of the School-Aged Child With Attention-
Deficit/Hyperactivity Disorder, 108 PEDIATRICS 1033 (2001) [hereinafter AAP Treatment
Guideline]. The American Academy of Child and Adolescent Psychiatry (AACAP) has
also issued practice parameters that include considerable overlap with the AAP clinical
practice guidelines. See American Academy of Child and Adolescent Psychiatry, Prac-
tice Parameter for the Use of Stimulant Medications in the Treatment of Children,
Adolescents, andAdults, 41 J. AM. ACAD. CHILD & ADOLESCENT PSYCHIATRY 26S (2002);
American Academy of Child and Adolescent Psychiatry, Practice Parameters for the
Assessment and Treatment of Children, Adolescents, and Adults with Attention-
Deficit/Hyperactivity Disorder, 36 J. AM. ACAD. CHILD & ADOLESCENT PSYCHIATRY 85S
(1997).
90. This section will focus on the involvement of primary care physicians and
pediatricians, as a majority of children with ADHD are diagnosed and treated by their
primary care clinicians. See Wolraich, supra note 71, at 23-3 - 23-4.
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1. AAP Diagnostic Guideline
The AAP guideline addressing diagnosis and evaluation of ADHD notes
that common presentations of ADHD in clinical practice include "referral
from school for academic underachievement and failure, disruptive class-
room behavior, inattentiveness, problems with social relationships, parental
concerns regarding similar phenomena, poor self-esteem, or problems with
establishing or maintaining social relationships., 91 The physician must have
input both from parents and from the school professionals working with the
child because symptoms may not be apparent in the clinical setting and
because the diagnostic criteria for ADHD require that the sy'mptoms should
be present in two or more settings (i.e., home and school). 9 The evaluation
and diagnosis of ADHD usually requires several steps and more than one
visit.
93
The diagnostic guideline includes six recommendations. The clinician
should initiate an evaluation for ADHD if a six- to twelve-year-old child
exhibits inattention, hyperactivity, impulsivity, academic underachievement,
or behavior problems. 94 The diagnosis of ADHD requires that a child meet
DSM-IV criteria. 95 ADHD assessment "requires evidence directly obtained
from parents or caregivers regarding the core symptoms of ADHD in various
settings, the age of onset, duration of symptoms, and degree of functional
impairment"; 96and "evidence directly obtained from the classroom teacher
(or other school professional) regarding the core symptoms of ADHD, the
duration of symptoms, the degree of functional impairment, and coexisting
conditions.' The child's evaluation "should include assessment for coexist-
ing conditions." 98 Finally, "other diagnostic tests are not routinely indicated
to establish the diagnosis of ADHD."
Under the fourth recommendation requiring evidence provided by school
personnel, the guideline suggests that the classroom teacher, who typically
has more information about the child's behavior than other school personnel,
should provide the report. If the teacher cannot provide the report, the
guideline suggests that a school counselor or principal can help to coordinate
91. AAP Diagnostic Guideline, supra note 11, at 1160.
92. Id. at 1162 (stating "[t]he diagnosis comes from a synthesis of information
obtained from parents; school reports; mental health care professionals, if they have been
involved; and an interview/examination of the child.").
93. Id. at 1159.
94. Id. at 1160 (Recommendation 1).
95. Id. at 1160 (Recommendation 2).
96. Id. at 1163 (Recommendation 3).
97. Id. at 1165 (Recommendation 4).
98. Id. at 1166 (Recommendation 5).
99. Id. at 1167 (Recommendation 6).
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such reporting and to provide the required information. 0 0 The guideline also
addresses teachers' use of certain questionnaires and rating scales that assess
behavioral conditions.' 0 '
2. AAP Treatment Guideline
The AAP guideline addressing treatment of children with ADHD recog-
nizes that clinicians' "[o]ngoing communication with parents, teachers, and
other school-based professionals is necessary to monitor the progress and
effectiveness of specific interventions."' 1 2 The treatment guideline includes
five recommendations. First, "clinicians should establish a long-term man-
agement program that recognizes ADHD as a chronic condition.""
1 3 This
recommendation stresses the need to establish a partnership among the
clinician, parents, teachers, and the child as well as the importance of moni-
toring care over time. It also stresses the importance of providing
information about the condition and observes that "[t]horough family under-
standing of the problem is essential before discussing treatment options and
side effects."
10 4
Second, the treating clinician, parents, and the child, in collaboration with
school personnel, "should specify appropriate target outcomes to guide
management."' 1 5 Third, "the clinician should recommend stimulant medica-
tion and/or behavior therapy as appropriate."' 1 6 Fourth, "when the selected
management plan has not met target outcomes, clinicians should evaluate the
original diagnosis, use of all appropriate treatments, adherence to the treat-
ment plan, and presence of coexisting conditions."' 0 7 This recommendation
emphasizes the importance of monitoring and evaluating treatment plans
through information gathered from parents, the child, and school personnel.
100. Id. at 1165.
101. Id. at 1166. For a detailed overview of scales used to assess ADHD, see Brent R.
Collett, Jeneva L. Ohan, and Kathleen Myers, Ten- Year Review of Rating Scales. V."
Scales Assessing Attention-Deficit/Hyperactivity Disorder, 42 J. AM. ACAD. CHILD &
ADOLESCENT PSYCHIATRY 1015 (2003).
102. AAP Treatment Guideline, supra note 89, at 1034.
103. Id. at 1036. (Recommendation 1).
104. Id.
105. Id. at 1036 (Recommendation 2).
106. Id. at 1037, 1039-40 (Recommendation 3). Behavior therapy in this context is
usually implemented by training parents and teachers in specific techniques of improving
behavior, and should be differentiated from psychological interventions directed to the
child. Schools may provide behavior therapy with teachers within the context of an
individual education plan (IEP) or under a Section 504 plan, which might include
preferential seating and a decreased assignment and homework load.
107. Id. at 1040 (Recommendation 4).
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Finally, "the clinician should periodically provide a systematic follow-up for
the child with ADHD. Monitoring should be directed to target outcomes and
adverse effects by obtaining specific information from parents, teachers, and
the child."' 8
3. Actual Practice
Studies have found that the recommendations included in the AAP guide-
lines are not generally followed.' 0 9 Many physicians have never received
medical training with respect to the diagnosis of ADHD 110 and may, there-
fore, need more specific details than are provided by the AAP guidelines.
I'
Due to the structure of many pediatric practices and limitations imposed by
some health insurance groups, many physicians are unable to spend adequate
time diagnosing children who may suffer from ADHD 112 or to have follow-
up visits with adequate frequency. 113 Physicians often do not communicate
with school personnel regarding dia nosis or monitoring of treatment, but
rely instead on input from parents. Finally, physicians fail to provide
108. Id. at 1041 (Recommendation 5) (recommending that once the child is stable, the
child should make an office visit every 3 to 6 months, and that the clinician should
continue to receive information from parents, the child, and school personnel throughout
treatment).
109. Kimberly Hoagwood et al., Treatment Services for Children with ADHD: A
National Perspective, 39 J. AM. ACAD. CHILD & ADOLESCENT PSYCHIATRY 198, 205
(2000) (observing that "[a]lthough at least 2 professional associations have written
guidelines or parameters for practice with these children (AACAP and American Acad-
emy of Pediatrics), and thorough evidence-based reviews have been completed
(McMaster University, 1998), these guidelines are not yet influencing care as delivered in
real-world practices"); see also Campbell and Glass, supra note 88, at 478-80 (discussing
how guidelines come to be adopted as a "professional norm" and observing that generally
there is "widespread enthusiasm for guidelines, but only a minimal impact on actual
clinical practices").
110. Laurel K. Leslie, Implementing the American Academy of Pediatrics Attention-
Deficit/Hyperactivity Disorder Diagnostic Guidelines in Primary Care Settings, 114
PEDIATRICS 129, 130 (2004).
111. Id. at 134.
112. Id. at 134-135; Wolraich, supra note 71, at 23-6 - 23-7.
113. Wolraich, supra note 71, at 23-8 - 23-9; See also Olfson, National Trends 2003,
supra note 45, at 1073-75 (noting decrease in psychotherapy visits by children with
ADHD).
114. Leslie, supra note 110, at 134 (suggesting that physicians are unsure of the
manner and timing for requesting evaluations from schools and fear that such requests
may overwhelm school personnel); Wolraich, supra note 71, at 23-5; NIH Conference
Statement, supra note 8, at 186.
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parents with adequate information regarding the disorder itself, possible side
effects of medication, and alternative treatments. 
11 5
4. Informed Consent
Almost all of the Ritalin cases included claims of failure to obtain in-
formed consent. 1 6 While states' informed consent laws vary, standards of
disclosure are generally measured by either professional standards or pa-
tient-oriented standards. 117 Under professional standards, the physician is
required to disclose what a reasonable medical practitioner would disclose
under the same or similar circumstance. The patient-oriented standard
requires the physician to disclose all information that a reasonable person in
the patient's circumstances would find material to making a decision regard-
ing treatment. States are split fairly evenly with respect to which standard
they follow," l8 and courts often overlook the line between the two stan-
dards.1 9
Courts and legislatures addressing informed consent generally require that
adequate disclosure include: information about the nature and purpose of the
proposed treatment, the risks and benefits of the proposed treatment, and
facts about available alternative treatments. 12 In addition, the physician
should be sure that the patient understands the information disclosed and
provides voluntary consent. 121
Some states only require informed consent for surgical or invasive proce-
dures, 122 while other states have enacted informed consent legislation for
specific procedures. 123 A few states have established disclosure panels that
115. Leslie, supranote 110, at 135.
116. Welke, supra note 20, at 157, 159 and accompanying text; see also Weathers
Complaint, supra note 52. The law of informed consent has largely developed through
state case law, although many state legislatures also have enacted laws governing
informed consent. These laws vary from state to state, and this article will only provide a
general outline of this doctrine. See Ketchup v. Howard, 543 S.E.2d 371, at 381 (Ga.Ct.
App. 2000) (providing a state-by-state overview of informed consent laws).
117. JESSICA W. BERG ET AL., INFORMED CONSENT: LEGAL THEORY AND CLINICAL
PRACTICE 46-52 (2d ed. 2001).
118. Id. at48.
119. Id. at 51.
120. Id. at 53.
121. Id. at 65-70 (noting that understanding and voluntariness are two of the most
vaguely defined concepts in informed consent law).
122. Id. at 54.
123. See, e.g., 40 PA. STAT. ANN. § 1303.504 (West Supp. 2004) (requiring informed
consent prior to conducting the following procedures: surgery, including the related
administration of anesthesia; administering radiation or chemotherapy; administering a
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specify which treatments and procedures require informed consent and that
prescribe the necessary disclosures.' 24 States also vary with respect to the
physician's duty to disclose alternatives, with some cases and statutes failing
to address the issue at all and other states enacting special statutes mandating
disclosure of alternatives to certain procedures, such as breast cancer treat-
ments. 125 Unfortunately, informed consent laws often serve to guide juries in




The earliest efforts to address psychotropic medication in the schools
came in the form of State Board of Education resolutions in Colorado 127 and
Texas. 128 While these resolutions lacked any legally binding effect, they
represent the first steps taken towards state regulation. In November 1999,
the Colorado State Board of Education passed a resolution encouraging
school personnel "to use proven academic and/or classroom management
blood transfusion; inserting a surgical device or appliance; or administering an experi-
mental medication, using an experimental device, or using an approved medication or
device in an experimental manner.)
124. BERG ET AL., supra note 117, at 58; See, e.g., TEX. CIV. PRAC. & REM. § 74.102
(Vernon Supp. 2004-2005).
125. BERG ET AL., supra note 117, at 60. See, e.g., CAL. HEALTH & SAFETY CODE §
109275(b)-(c)(1) (West 1996).
126. BERG ETAL., supra note 117, at 53, 130.
127. Colo. State Bd. of Educ., Resolution: Promoting the Use ofAcademic Solutions
to Resolve Problems with Behavior, Attention, and Learning (Nov. 11, 1999), available
at http://www.cde.state.co.us/cdeboard/download/resBehavior.pdf [hereinafter Colorado
Resolution]. See Michael Janofsky, Colorado Fuels US. Debate Over Use of Behavioral
Drugs, N.Y. TIMES, Nov. 25, 1999, at AI. The Colorado resolution was passed largely in
response to the Columbine high school shootings. Proponents of the resolution were
motivated by evidence linking the use of psychotropic medication and school violence.
While one of the teenage shooters at Columbine had been taking an antidepressant, there
is no indication that a teacher recommended the use of the medication. The resolution's
sponsor also cited anecdotal reports of school personnel pressuring parents to medicate
their children. Id.
128. Tex. State Bd. of Educ., Resolution on the Use of Psychiatric Drugs by Students,
(Nov. 3, 2000), available at http://www.tea.state.tx.us/sboe/minutes/sboe/2000/
0011 resolve.html, reprinted in 180 EDUC. REP.: THE NEWSPAPER OF EDUC. RTS. (Jan.
2001) [hereinafter Texas Resolution].
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solutions to resolve behavior, attention and learning difficulties" and en-
couraging "greater communication and education among parents, educators,
and medical professionals about the effects of psychotropic drugs on student
achievement and our ability to provide a safe and civil learning environ-
ment." 129 The Colorado resolution sparked both local and national debate,
130
and the Texas State Board of Education passed a similar resolution the
following year.131
In 2001, Connecticut' 32 and Minnesota 33 passed the first laws addressing
schools' involvement in psychotropic drug issues, and other states have
followed. Unlike the school board resolutions, the state laws do not pass
judgment upon the validity of psychiatric diagnoses or presume to identify
preferred courses of treatment. 134 While the state laws vary, the legislation
generally falls into three categories: legislation prohibiting school personnel
from recommending the use of psychotropic drugs;135 legislation prohibiting
129. Colorado Resolution, supra note 127.
130. For the debate leading up to the resolution, see Peter G. Chronis, Drugs for
Unruly Children Attacked: State Legislators Told of School- Violence Ties, DENVER POST,
Nov. 10, 1999, at A-01; Editorial, Far Too Sure About Ritalin, DENVER ROCKY MOUN-
TAIN NEWS, Nov. 11, 1999, at 68A; Peter G. Chronis, Board To Soften Drug Resolution:
Testimony Supports Medication for Kids, DENVER POST, Nov. 11, 1999, at B-0 1. For the
debate following adoption of the resolution, see Janofsky, supra note 127; Ann Schrader,
Drugging Kids: No Easy Fix, Recent School Violence Brings Debate to Fore, DENVER
POST, Nov. 22, 1999, at A-01.
131. Texas Resolution, supra note 128.
132. 2001 Conn. Acts 01-4, § 11 (June Spec. Sess.) (codified as amended at CONN.
GEN. STAT. ANN. § 10-212b (West Supp. 2005)).
133. 2001 Minn. Laws 1st Spec. Sess., c. 6, art. 3, §§ 1, 14 (codified as amended at
MINN. STAT. ANN. § 121A.41(10) (West Supp. 2004).
134. Colorado Resolution, supra note 127; Texas Resolution, supra note 128. While
both resolutions correctly observed that only medical personnel can recommend the use
of prescription medication, both also cited "documented incidents of highly negative
consequences in which psychiatric prescription drugs have been utilized for what are
essentially problems of discipline which may be related to lack of academic success."
Colorado Resolution, supra note 127; Texas Resolution, supra note 128.
135. COLO. REV. STAT. § 22-32-109(l)(ee) (2004) (requiring school boards to adopt a
policy prohibiting school personnel from recommending or requiring the use of a
psychotropic drug by any student; permitting school personnel to suggest consultation
with an appropriate health care professional); CONN. GEN. STAT. ANN. § 10-212b (West
Supp. 2004) (defining psychotropic drugs broadly to include prescription medications for
behavioral and social-emotional concerns, including, but not limited to, stimulants and
antidepressants; requiring school boards to adopt policies prohibiting any school person-
nel from recommending the use of psychotropic drugs for any child; permitting school
health personnel to recommend medical evaluation of a child; permitting school person-
nel to consult with medical practitioner with parent's consent); OR. REV. STAT. § 339.873
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school personnel from reqluiring the use of psychotropic drugs as a condition
of continued enrollment;16 and legislation stating that a parent or guardian's
refusal to medicate a child with psychotropic drugs does not constitute
neglect. 137 In man, states that have not yet enacted such legislation, similar
bills are pending.
(West Supp. 2004) (prohibiting school personnel from recommending that a student seek
a prescription for psychotropic medication; permitting school personnel to communicate
with parent regarding the behavior of the student at school; specifying that school district
is not relieved of duty to identify, locate and evaluate students with disabilities); TEX.
EDUC. CODE ANN. § 38.016 (Vernon Supp. 2004-2005) (defining psychotropic drugs
broadly as medication intended to have an altering effect on perception, emotion, or
behavior; prohibiting school personnel from recommending that a student use a psycho-
tropic drug or suggesting any particular diagnosis; permitting school health personnel to
recommend medical evaluation of a child; requiring the board of trustees of each school
district to adopt policy implementing and enforcing statute); VA. CODE ANN. § 22.1-274.3
(2003) (defining psychotropic medications broadly to include those intended to alter
mental activity or state, including, but not limited to, antipsychotic, antidepressant, and
anxiolytic [anti-anxiety] medication and behavior-altering medication; requiring Board of
Education to develop policies prohibiting school personnel from recommending the use
of psychotropic medications for any student; permitting school personnel to recommend
medical evaluation of a student; permits school personnel to consult with such practitio-
ner with parent's written consent.)
136. COLO. REV. STAT. § 22-32-109(l)(ee) (2004) (requiring school boards to adopt a
policy prohibiting school personnel from recommending or requiring the use of a
psychotropic drug by any student); 105 ILL. COMP STAT. § 5/10-20.35 (West Supp. 2004)
(defining psychotropic medication broadly to include medication used for antipsychotic,
antidepressant, antimanic, antianxiety, behavioral modification or behavioral manage-
ment purposes; requiring school boards to adopt a policy prohibiting any disciplinary
action based on a parent's refusal to administer psychotropic medication to the student;
requiring training of school personnel on the identification and treatment of ADHD, the
application of non-aversive behavioral interventions in school, and the use of psychotro-
pic medication for children; permitting school medical staff, IEP team, or specified
trained specialists to recommend medical evaluation of the student and to consult with
such practitioner with parent's consent.); MINN. STAT. ANN. § 121A.41 (10) (West Supp.
2004) (prohibiting school from requiring parent of suspended student to provide sym-
pathomimetic [stimulant] medication as a condition of readmission); TEX. EDUC. CODE
ANN. § 38.016 (Vernon Supp. 2004-2005) (prohibiting school personnel from using
parent's refusal to consent to administration of psychotropic medication to a student or to
a psychiatric evaluation or examination of the student as grounds, by itself, for prohibit-
ing the child from attending a class or participating in a school-related activity).
137. CONN. GEN. STAT. ANN. § 17a-131a (West Supp. 2004) (stating that parent's
refusal to administer or consent to the administration of psychotropic drugs to children
shall not, in and of itself, constitute grounds for the state to take child into custody unless
such refusal causes the child to be neglected or abused as defined by statute); MINN.
STAT. ANN. §§ 260A.01 (b), 260C. 163(11)(b) (West 2005) (stating that parent's refusal to
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Congress also has turned its focus to school personnel recommending the
use of psychotropic medication for children. 139 Shortly after the Colorado
School Board of Education approved its resolution encouraging the use of
classroom management solutions to resolve behavior, attention, and learning
difficulties, a similar resolution was introduced in Congress. 140 Informa-
tional hearings on children's use of behavioral drugs were held in May
2000, September 2000,142 and September 2002.1% In May 2003, the
provide child with sympathomimetic [stimulant] medications does not constitute educa-
tional neglect); TEX. EDUC. CODE ANN. § 26.0091 (Vernon Supp. 2004-2005) (prohibiting
school personnel from using or threatening to use parent's refusal to administer or to
consent to the administration of a psychotropic drug to child, or to consent to any other
psychiatric or psychological testing or treatment of child, as the sole basis for making a
report of neglect of the child unless the employee has cause to believe that the refusal
presents a substantial risk of death, disfigurement, or bodily injury to the child, or has
resulted in an observable and material impairment to the growth, development, or
functioning of the child); TEX. FAM. CODE ANN. § 261.111 (Vernon Supp. 2004-2005)
(stating that parent's refusal to administer or to consent to the administration of a psycho-
tropic drug to child, or to consent to any other psychiatric or psychological testing or
treatment of child, does not by itself constitute neglect of the child unless the refusal
presents a substantial risk of death, disfigurement, or bodily injury to the child, or has
resulted in an observable and material impairment to the growth, development, or
functioning of the child). For a discussion of medical and educational neglect, see
Komoroski, supra note 56, at 113-20.
138. For an updated list of pending legislation, see American Academy of Child and
Adolescent Psychiatry, AACAP State Psychotropic Medication Update, available at
http://www.aacap.org/legislation/State/.
139. Prior to 2000, Congress held two informational hearings on the use of psychotro-
pic medications in schools. See 1970 Hearings, supra note 1; Oversight of the Dep't of
Educ. and the Nat'l Inst. of Mental Health: Current Approaches to Attention Deft-
cit/Hyperactivity Disorders: Hearing Before the Subcomm. on Human Resources and
Intergovernmental Relations of the H. Comm. on Gov't Reform and Oversight, 104th
Cong. (1996).
140. H.R. Res. 459, 106th Cong. (2000) (recognizing state and local control of public
education) The resolution called for Congress to conduct hearings, recommend studies,
support state and local education agency efforts, encourage school personnel to use
proven academic and classroom management solutions for problems of behavior,
attention, and learning difficulties, and urge greater communication between and educa-
tion of parents, educators, and medical professionals. Id.
141. Ritalin Use Among Youth: Examining the Issues and Concerns: Hearing Before
the Subcomm. on Early Childhood, Youth and Families of the H. Comm. on Educ. and the
Workforce, 106th Cong. (2000). During the hearings, representatives made statements
regarding schools pressuring parents to medicate their children. See, e.g., id. at 6-8
(statement of Rep. Deborah Pryce, Member, H. Comm. Educ. and Workforce) (relating
anecdotal accounts of parents being pressured by schools to place children on stimulant
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House of Representatives passed the Child Medication Safety Act
(CMSA), 14 4 requiring states receiving funds administered by the U.S. De-
partment of Education to establish policies and procedures that prohibit
school personnel from requiring a child to obtain a prescription for sub-
stances covered by section 202(c) of the Controlled Substances Act 14 5 as a
condition of attendance or receipt of school services. The legislation was
referred to the Senate, where it was not reported out of committee. 146
In 2004, Congress reauthorized and amended IDEA through enactment of
the Individuals with Disabilities Education Improvement Act. 14 7 Under the
reauthorized Act, state education agencies must require schools receiving
funds under IDEA to prohibit school personnel from mandating the use of
medication covered by the Controlled Substances Act as a prerequisite for
attendance or receipt of services.148 The statute specifically clarifies that this
prohibition should not be construed so broadly as to prohibit school person-
nel from communicating with parents regarding a student's academic
performance, behavior, or the need for an evaluation to determine eligibility
for special education services. 149 The House Committee Report explains the
rationale for this section:
The Committee has been made aware of incidents where local educational
agency officials have required parents to place children on psychotropic
medication in order to attend school or receive services. The Committee
feels that school officials should not presume to know what medication a
child needs, or if the child even needs medication. Only medical doctors
have the ability to determine if a prescription for a psychotropic drug is
medication and stating that while "[a]t first blush, you would think that Ritalin is a
medical issue, ... the input from [her] constituents reveals that the schools are very, very
much involved"); id. at 8-10 (statement of Rep. Dennis Kucinich Member, H. Comm.
Educ. and Workforce) (noting that the issue first came to his attention following a news
series in Cleveland about parents "being pressured to seek Ritalin prescription[s] for their
child[ren] by a small number of well-intentioned, but misinformed, school administrators
and teachers").
142. Hearings on Behavioral Drugs in Schools, supra note 56.
143. Attention Deficit/Hyperactivity Disorder-Are We Overmedicating Our Chil-
dren?: Hearing Before the H. Comm. on Gov 't Reform, 107th Cong. (2002).
144. H.R. 1170, 108th Cong. (2003).
145. 21 U.S.C. § 812(c) (2000) (listing substances covered by the Controlled Sub-
stances Act).
146. In 2005, Rep. John Kline reintroduced CMSA. See Child Medication Safety Act
of 2005, H.R. 1790, 109th Cong.
147. Individuals with Disabilities Education Improvement Act of 2004, Pub. L. No.
108-446, 118 Stat. 2647 (effective July 1, 2005).
148. Id. § 612 (a)(25)(A).
149. Id. § 612 (a)(25)(B).
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appropriate for a child. However, the Committee wants to stress the impor-
tance of open and effective communication between the parent and school
officials (including teachers) regarding the needs of the child as a whole.
150
While few question that school personnel should not recommend or re-
quire the use of psychotropic medication, 151 there is some debate over
whether or not legislation prohibiting such action is necessary. Although
there are some well-publicized cases of such coercion, proponents of legisla-
tion largely rely on anecdotal accounts of such pressure. They argue that
parents feel intimidated and therefore perceive undue pressure when these
recommendations come from school personnel.1 53 While some proponents
agree that coercion may be rare, they argue that if it is happening in any
instance, the legislation is justified and necessary.'54
Many educators and health care professionals oppose legislation on the
basis that it is not necessary. In their view, it is clear that schools should not
150. H. REP. No. 108-77, at 99 (2003).
151. See, e.g., Protecting Children: The Use of Medication in Our Nation's Schools
and H.R. 1170, Child Medication Safety Act of 2003: Hearing Before the H. Subcomm.
On Educ. Reform of the Comm. on Educ. and the Workforce, 108th Cong. 12 (2003)
(statement of Dr. Lance Clawson, private psychiatrist, Cabin John, Md.) ("[M]y sense is
that it is not the purview of educators to recommend medication. They know that."); id. at
24 (statement of Rep. Chris Van Hollen, Member, H. Comm. Educ. and Workforce) ("I
think from the testimony on all sides, it is clear that no one thinks that teachers should be
prescribing Ritalin or saying that we should require kids as a condition to going to school
to take Ritalin").
152. Andrew Julien, Reading, Writing and Ritalin Today: Lawmakers Consider
Guidelines for the Role of Behavior-Modifying Medication in Learning, HARTFORD
COURANT, Mar. 15, 2001, at Al (paraphrasing State Rep. Lenny T. Winkler, sponsor of
the Connecticut legislation); Panel Votes to Curb Schools' Drug Advice: Bill Discour-
ages Urging Medicine for Unruly Kids, DENVER POST, Feb. 14, 2002, at A14 (reporting
that several Colorado parents testified that public school officials recommend medicating
children when the child does not behave or perform well).
153. Carrie Budoff, House Approves Bill on Child Behavior: Measure Would Ban
School Officials from Suggesting Drugs, HARTFORD COURANT, May 23, 2001, at A6
(noting the argument that since teachers are held in such high esteem, parents tend to
listen to their recommendations even though they are not qualified to be recommending
medication); John Sanko, It Was a Quick Fix, Take a Pill: School Personnel Urge
Behavior-Control Drugs, Senate Hearing Is Told, ROCKY MOUNTAIN NEWS, Mar. 14,
2002, at A20 ("noting parents feel very intimidated when they walk into a school setting
where teachers and others tell them their children should be put on behavioral drugs").
154. Budoff, supra note 153 (reporting that although Connecticut's Office of Protec-
tion and Advocacy for Persons with Disabilities received only a "handful" of complaints
about the issue over the preceding 18 months, the executive director of that office thought
that was certainly enough to warrant legislative action on the issue).
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be recommending medication and such recommendations do not occur.
55
Opponents worry that legislation could have a chilling effect on communica-
tion between parents and teachers.156 Finally, there are those who claim that
even if schools do make medication recommendations, it is the parent and
physician who make the ultimate decision, and the physician who writes the
prescription.157
B. Medical Profession
While the AAP guidelines seek to establish standards for the diagnosis
and treatment of ADHD, 158 including communication with parents and
schools, the guidelines have not yet been widely adopted and an array of
problems persists. 159 Many times, physicians do not spend adequate time
evaluating and monitoring patients. Parents do not receive adequate informa-
tion. Teachers and school personnel are not consulted during the diagnostic
process or once treatment begins. Primary care physicians fail to provide the
follow up treatment necessary after prescribing stimulant medication.
Studies also have found that treatment of children with presumably similar
needs varies widely, and researchers have suggested that physicians require
greater training.'60
Responding to these concerns, Indiana has enacted legislation aimed at
physicians' practices in prescribing psychotropic medication for children,
161
155. Julien, supra note 152 (noting that "[a] wide range of educators say that the
underlying premise of [the] proposed legislation is accurate - that [it is] not the job of
school officials to diagnose or order treatment options. But they also say that educators
already understand their role and that a new law is not necessary").
156. Individuals with Disabilities Education Improvement Act of 2004, Pub. L. No.
108-446, § 612, 118 Stat. 2647, 2691 attempts to address this concern by affirmatively
stating that the Act does not prohibit communications regarding academic performance,
behavior, or the need for an evaluation or services. See H. REP. No. 108-77, at 99 (2003).
157. Julien, supra note 152 (discussing a pediatric neurologist who agrees that some
teachers may be too aggressive but believes legislation governing school personnel is
unnecessary because the decision ultimately lies with the doctor and the parent).
158. See supra notes 88-108 and accompanying text.
159. See supra notes 109-15 and accompanying text.
160. Kimberly Hoagwood, et al., Treatment Services for Children With ADHD - A
National Perspective, in ATTENTION DEFICIT HYPERACTIvITY DISORDER: STATE OF THE
SCIENCE, BEST PRACTICES 22-16 (Peter S. Jensen and James R. Cooper, eds., 2002)
("Residency programs and continuing education training for general practice physicians
who are likely to see increasing number of children with this condition are necessary to
ensure that knowledge about best practices and the limits of expertise (i.e., when referral
is appropriate) is disseminated widely.")
161. IND. CODE ANN. § 25-1-9-6.8 (LexisNexis Supp. 2004).
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and several state legislatures have considered bills on the subject. Indiana
requires medical practitioners to follow the most recent AAP or AACAP
guidelines for diagnosing and evaluating a child with ADHD symptoms
before prescribing stimulant medication. Other states have considered, but
not passed, bills addressing physician education in the use of psychotropic
medication for children 163 and the establishment of guidelines by state
boards of medicine.' 64 These proposed laws have varied in their approaches.
Some require the state board of medical examiners to adopt training proce-
dures 165 or to establish guidelines and procedures to be followed before
prescribing psychotropic medication to children. 66 Others require specific
training for physicians who prescribe such medications.
67
While moving in the right direction, neither the Indiana law nor the bills
introduced in other states include provisions regarding both training and
procedural guidelines. Additionally, in some instances, the legislators assert
medical judgments that are beyond the scope of their expertise. For example,
the Indiana law specifies which guidelines medical practitioners must follow
rather than delegating that determination to a medical board or panel. The
Arkansas bill included language similar to the Colorado and Texas school
board resolutions regarding "negative consequences" and questioning the
validity of the disorder. 168
In addition to training and guidelines, some states have considered bills
addressing the prescription of psychotropic medication to children and
informed consent. 69 The California Senate considered such legislation in
2002. 17 The bill would have required a physician to obtain a signed consent
form before prescribing, dispensing, or furnishing a Schedule II psychotro-
162. Id.
163. See, e.g., H.B. 1870, 83rd Gen. Assem. (Ark. 2001) (requiring doctors who
prescribe psychotropic drugs to have training in child psychology and development and
training in the use and effects of psychotropic drugs on children); H.B. 3630, 71 " Leg.
Assem. (Or. 2001) (requiring Board of Medical Examiners to adopt training procedures
for physicians who prescribe and dispense psychotropic medication to children).
164. See e.g., S.B. 26, 2001 Reg. Sess. (Ala. 2001) (requiring a certain evaluation and
management procedure for physicians treating children with psychotropic medication;
authorizing the State Board of Medical Examiners to establish and enforce procedures to
be followed by physicians prior to prescribing psychotropic medication to children).
165. H.B. 3630, 71st Leg. Assem. (Or. 2001).
166. S.B. 26, 2001 Reg. Sess. (Ala. 2001).
167. H.B. 1870, 83rd Gen. Assem. (Ark. 2001).
168. Id.; see supra notes 122-23 and accompanying text.
169. See e.g., H.B. 2635, 45th Leg., Reg. Sess. (Ariz. 2002); S.B. 1290, 2001-2002
Reg. Sess. (Cal. 2002); H.B. 29, 141st Gen. Assem. (Del. 2001); H.B. 7669, 2000 Sess.
(R.I. 2000).
170. S.B. 1290, 2001-2002 Reg. Sess. (Cal. 2002).
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pic drug primarily used to treat ADHD to a child. The bill would have
required a physician to inform a child's parent or guardian of their right to
accept or reject the use of the psychotropic drug. It also would have required
a physician to provide specified information, including reasonable alterna-
tive treatments and probable side effects, so that the parent or guardian could
make an informed decision. The signed consent form would have included
information prepared by the State Department of Health concerning effects
of the psychotropic drug. Any violation of these requirements would have
constituted unprofessional conduct on the part of the physician or surgeon.
Medical groups, including the California Psychiatric Association, the
California Medical Association, and the American Academy of Pediatrics,
opposed the bill. 171 They asserted that the bill was unnecessary because
physicians are already required to obtain informed consent.' 72 In their view,
additional requirements would unduly burden physicians and have a detri-
mental effect on the physician's ability to communicate with parents.
Physicians also suggested that the legislation would have a chilling effect on
the prescription of such medication.
The California Senate Health and Human Services Committee analysis of
the bill questioned whether the bill was necessary, given both current in-
formed consent requirements and existing mandates that doctors prescribing
Schedule II drugs comply with additional requirements. 73 The analysis also
notes that proponents of the bill did not provide evidence of widespread
problems of doctors failing to obtain informed consent. 174 Ultimately, the
bill died in committee.
V. SUGGESTED LEGISLATIVE RESPONSE
State legislatures have clearly recognized a need to address the diagnosis
and treatment of ADHD and other neurobehavioral disorders in children, and
specifically the use of psychotropic medication in that course of treatment.
171. Cal. S. Health & Human Serv. Comm., Staff Analysis of Senate Bill 1290 15-17
(May 13, 2002), available at http://www.leginfo.ca.gov/pub/01-02/bill/sen/sb 1251-
1300/sb 1290_cfa 20020513 143147_sen comm.html [hereinafter StaffAnalysis].
172. See Cobbs v. Grant, 502 P.2d 1 (Cal. 1972) (setting forth California's legal
requirements for informed consent, which require the physician to discuss risks, compli-
cations and expected benefits of treatment, including likelihood of success, and
alternatives to treatment, including risks and benefits thereof).
173. StaffAnalysis, supra note 171, at 18.
174. Id. at 19, but cf sources cited supra notes 141 and 152 (one could argue that just
as anecdotal evidence has been used to support passage of legislation governing the
actions of school personnel, anecdotal evidence and claims made in suits can be used to
support legislation governing the actions of medical practitioners).
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Although federal law will now require state educational agencies to prohibit
school personnel from requiring medication as a condition of attendance or
eligibility for special education services, 75 it is not clear what form such
prohibitions must take.176 The federal law only addresses one of the issues
that have arisen in schools. States, therefore, need to take a more compre-
hensive view of the problem and enact multi-faceted legislation governing
both school personnel and medical practitioners.
Given that some school personnel have recommended or attempted to
require medication, such legislation is warranted to protect the rights of
students and parents. Additionally, such legislation is necessary to help
school personnel draw clear lines when identifying students with special
education needs and when communicating with parents about behavioral
issues. Likewise, there is a need for legislation governing physicians who
diagnose neurobehavioral disorders and prescribe psychotropic medication
for children. Within the medical community itself, there is concern regarding
both under-prescription and over-prescription of medication due to a lack of
training and guidelines, 177 and parents have asserted that they have not been
properly informed about treatment options or side effects. 78
A. School Legislation
State legislation with respect to school personnel should broadly define
psychotropic medication to include any prescription medications intended to
have an altering effect on behavior or emotions, including but not limited to
stimulant medication, antidepressants, and anti-anxiety medication. 79 The
legislation should address all three areas noted in Part IV of this article:'
8 0
schools recommending psychotropic medication, schools attempting to
175. Individuals with Disabilities Education Improvement Act of 2004, Pub. L. No.
108-446, 118 Stat. 2647 (effective July 1, 2005).
176. See, e.g., Memorandum from James A. Kadamus, Deputy Comm'r, Office for
Elementary, Middle, Secondary and Continuing Educ., N.Y. Dep't. of Educ. to Dist.
Superintendents of Sch., Superintendents of Public Sch., Charter Sch., Dir. of Special
Educ., and Chairpersons of Comm. on Special Educ. (Aug. 15, 2002), available at
http://www.emsc.nysed.gov/deputy/Documents/ritalin.html (advising all schools in New
York that school personnel could not require parents to administer Ritalin or psychotropic
medication as a condition of enrolling their child in school). It is not clear if this memo
would be sufficient to meet the federal requirement.
177. See supra note 10 and accompanying text.
178. See supra notes 115-16 and accompanying text.
179. See CONN. GEN. STAT. ANN. § 10-212b (West Supp. 2004); TEX. EDUC. CODE
ANN. § 38.016(2) (Vernon Supp. 2004-2005); VA. CODE ANN. § 22.1-274.3 (2003).
180. See supra notes 135-37 and accompanying text.
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require psychotropic medication, and schools reporting parents under neglect
statutes for failure to administer psychotropic medication.
State statutes should require local school boards to adopt and implement
policies prohibiting school personnel from recommending the use of psycho-
tropic medication or suggesting any diagnosis of neurobehavioral
disorders.181 Such policies should establish procedures for non-health school
personnel-i.e., teachers-to communicate their concerns about a child's
behavioral problems or suspected health-related academic difficulties to
school health personnel. The policies should create a procedure for commu-
nication with the parent or guardian, which might require that school health
personnel initiate such contact.182 School personnel should take a team
approach in communicating and meeting with parents, and in recommending
that a student receive a medical evaluation. Additionally, the policies should
encourage school personnel to offer their observations to assist the medical
practitioner in the evaluation of the child. School policies should set forth
procedures for obtaining the proper consent from parents in such cases.
Finally, the policies should require regular training for school personnel in
both appropriate administrative steps they might take when they suspect a
child suffers from a neurobehavioral disorder and in academic and class-
room management strategies in teaching children who may suffer from such
disorders. 8
In addition to enumerating items that should be included in school board
policies, state legislation should include a section clarifying what the legisla-
tion does not limit. In this way, legislatures can attempt to draw clear lines
for school personnel. The legislation should clarify that it seeks to preserve
open lines of communication between parents and school personnel regard-
ing students' academic performance and behavior in school by providing
guidelines for how such communication can be handled most effectively and
professionally. The legislation should make clear that it does not prohibit
school personnel from recommending an evaluation by a medical practitio-
ner, as long as personnel follow appropriate school board policies. Finally,
the statute should affirmatively state that it does not alter the school district's
181. See TEX. EDUC. CODE ANN. § 38.016(b)(I)-(2) (Vernon Supp. 2004-2005).
182. CONN. GEN. STAT. ANN. § 10-212b (West Supp. 2005). Connecticut's law
establishes the proper means of communication.
183. 105 ILL. COMP STAT. § 5/10-20.35 (West Supp. 2004) requires training at least
once every 2 years on "current best practices regarding the identification and treatment of
attention deficit disorder and attention deficit hyperactivity disorder, the application of
non-aversive behavioral interventions in the school environment, and the use of psycho-
tropic or psychostimulant medication for school-age children." Id. The statute seems to
go beyond what should be required of teachers in terms of knowledge regarding diagno-
sis and treatment of ADHD, and may increase teachers' confusion regarding their
appropriate role.
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obligation to identify and evaluate students who may qualify for special
education and related services under IDEA or Section 504.184
States also should enact legislation explicitly stating that school personnel
cannot require parents to place their children on psychotropic medication or
to submit to a medical evaluation as a condition of attendance. Although
federal law will now require state education agencies to prohibit schools
from requiring psychotropic medication, this prohibition should be codified
in state law as part of a comprehensive approach to the issue. The language
of the Texas statute provides a model for legislation in this area.185
Legislation also should state affirmatively that a parent's refusal to place a
child on psychotropic medication recommended or prescribed by a medical
practitioner cannot be the sole basis for making a child neglect report to the
state child protective services agency, and that such action on the part of a
parent does not in and of itself constitute neglect. As part of the state's
comprehensive approach to psychotropic medication prescriptions for
children, the law should cover school personnel as well as all other individu-
als.'
86
B. Medical Practitioner Legislation
Just as states should enact legislation governing school personnel recom-
mending or requiring psychotropic medication for children, state legislatures
should also enact legislation governing medical practitioners. Similar to
legislation requiring school boards to adopt certain policies, state law should
require state medical boards or panels to adopt and implement policies
regarding training of physicians who prescribe psychotropic medication as
well as guidelines and procedures for diagnosis and treatment.
Legislation should address training required for physicians who will diag-
nose and treat children with ADHD and other neurobehavioral disorders.
This training should include all facets involved in the diagnosis and treat-
ment of neurobehavioral disorders, including the prescription of
psychotropic medication as well as alternative treatments. Legislation also
184. See CONN. GEN. STAT. ANN. § 10-212b(b)(3)(C) (West Supp. 2004); OR. REv.
STAT. 339.873 (West Supp. 2004).
185. TEX. EDUC. CODE ANN. § 38.016(b)(3) (Vernon Supp. 2004-2005).
186. Texas addresses the issue of neglect in two separate statutes. TEX. EDUC. CODE
ANN. § 26.0091 (Vernon Supp. 2004-2005) (prohibiting school personnel from using or
threatening to use a parent's refusal to administer a psychotropic drug to a child or to
consent to psychiatric testing or treatment as the sole basis for making a neglect report);
TEX. FAM. CODE ANN. § 261.111 (Vernon Supp. 2004-2005) (stating generally that the
refusal to administer a psychotropic drug to a child or to consent to psychiatric testing or
treatment does not by itself constitute neglect).
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should require guidelines, including informed consent requirements, for
medical practitioners who prescribe psychotropic medication to children.
Such guidelines should foster cooperation among medical practitioners,
parents, and educators in the diagnosis and treatment of children with
neurobehavioral disorders. Although it is clear that the AAP and AACAP
diagnostic and treatment guidelines would serve as excellent models for
ADHD patients, state legislatures should defer to medical experts to identify
and define the required training programs and treatment guidelines.
Guidelines regarding informed consent should ensure that adequate dis-
closure includes certain basic elements, such as information about the nature
and purpose of the proposed treatment, the risks and benefits of the proposed
treatment, and facts about available alternative treatments. While informed
consent must be required when psychotropic medication is prescribed to
children, enacting informed consent legislation cannot be the sole, or even
primary, approach to the problem. As the reaction of the medical community
in California makes clear, the medical profession is not receptive to addi-
tional requirements in this area. 187 Rather than solely focusing on new
requirements that will ultimately be enforced in the courts, all involved
would be best served by legislation aimed at providing guidelines and
training and at fostering the cooperation of medical practitioners with
parents and school personnel.
CONCLUSION
State legislatures have appropriately begun to address the identification,
diagnosis, and treatment of children with ADHD and other neurobehavioral
disorders. While there are many children who are properly diagnosed, and
who benefit from treatment including psychotropic medication, there are
also children who are not receiving proper care. Legislative action is long
overdue, as debate surrounding neurobehavioral disorders in children and
the use of psychotropic medication to treat them has continued for over
thirty years. This debate has played out in courts, school boards, state
legislatures, and Congress. The popular media has influenced much of the
debate, and has sharpened the focus on school personnel attempting to
recommend or require medication for students. Because of this focus, most
187. See Staff Analysis, supra note 171 and accompanying text. See also BERG ET AL.,
supra note 117, at 161 (observing that the medical profession views informed consent as
"a pernicious, alien doctrine imposed by a hostile legal system. More stringent legal rules
are not the answer, since they will only evoke increased resistance from physicians, who
after all still remain largely in control of both the content and tone of doctor-patient
interactions").
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state action to date has been aimed at educators. While school personnel do
require stronger guidelines, state legislatures should take a more comprehen-
sive view of the diagnostic and treatment process. Because this process
necessarily involves medical practitioners, school personnel, and parents,
states should enact laws that will foster cooperation between all involved.
School personnel are required under federal laws to identify children who
may qualify for special education services, and state legislatures must draw
clear lines between identification and diagnosis, and must require policies
prohibiting school personnel from recommending or attempting to require a
course of treatment. Legislation should affirmatively state that schools
cannot require that a child be medicated as a condition of enrollment, and
that a parent's failure to medicate with psychotropic medication cannot, in
and of itself, constitute neglect. Legislation must be carefully crafted to
preserve open communication between educators and parents, and, with
parental consent, between educators and medical practitioners.
Only physicians can make a medical diagnosis and prescribe a course of
treatment. State laws, therefore, should mandate that physicians who diag-
nose and treat children with ADHD and other neurobehavioral disorders
receive specified training and follow diagnostic and treatment guidelines,
including informed consent requirements. The legislature should delegate
the identification or development of the specific training requirements and
diagnostic and treatment guidelines to a state medical board or panel.
Enacting such legislation will not resolve all of the controversy regarding
the use of psychotropic medication for children. It will, however, go far in
improving the process of diagnosing and treating children with ADHD and
other neurobehavioral disorders by simply drawing boundaries for school
personnel and requiring that physicians obtain training and follow guide-
lines. Equally important, this legislation will foster much more information
sharing and collaboration among educators, medical practitioners and
parents, and ultimately benefit children requiring diagnosis and treatment.
